Condition
Degenerative Lumbar Disc Disease
Total Trials
5
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Completed4
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07222787Not ApplicableRecruiting
Post-market Safety and Effectiveness of the CORUS-LX System in Improving Lumbar Interbody Fusion Outcomes
NCT02272140CompletedPrimary
Advanced XLIF Monitoring Multicenter Study
NCT02192112CompletedPrimary
Advanced XLIF Monitoring Pilot Study
NCT00493558Phase 4Completed
Spine Research With Roentgen Stereophotogrammetric Analysis
NCT00405600Not ApplicableCompletedPrimary
Spine Fusion Instrumented With BMP-2 vs Uninstrumented With Infuse BMP-2 Alone
Showing all 5 trials